Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. MarketScreener Strategies
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Stock Pick
Novo Nordisk AS : Global leader in diabetes treatments
Novo Nordisk is the world leader in diabetes treatments and a long-standing rival of Sanofi. The company has successfully negotiated the repositioning of its portfolio.
More Recommendations
Stock Trading Strategies
NOVO NORDISK A/S - 2020
A good level to buy
BUY
More Stock Trading Analysis
Official Publications
05/051st quarter report 
04/30Monthly statement on outstanding equity sh.. 
03/25Proxy Statments 
03/02Press Release 
02/23Mixed general shareholder meeting 
20204th quarter report 
Upcoming event on NOVO NORDISK A/S
06/28/21
Upcoming sector events
07/21/21NOVARTIS AG : Interim 2021 Earnings Release
07/21/21JOHNSON & JOHNSON : Interim 2021 Earnings Release
07/22/21ROCHE HOLDING AG : Interim 2021 Earnings Release
07/23/21ABBVIE INC. : Interim 2021 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals